Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Collagenase Therapy for Residual-type Dupuytren's Disease
NCT00260429Phase 3Completed
- Sponsor
- Stony Brook University
- Start
- Jun 2003
- Primary completion
- Aug 2005
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Dupuytren's disease, sponsored by Stony Brook University. Started Jun 2003; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's disease
Beyond the preview
Go deeper on NCT00260429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00260429.